Kazia Therapeutics Limited (KZIA) Financials

KZIA Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 18.1 million 10.3 million
2023-06-30 18.6 million 10.6 million
2023-03-31 ? ?
2022-12-31 19.0 million 11.1 million

KZIA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -4.1 million 137814
2023-06-30 ? ?
2023-03-31 -2.1 million 71944
2022-12-31 -6.0 million 643526

KZIA Net Income

No data available :(

KZIA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 3.4 million - -
2023-06-30 3.5 million - -
2023-03-31 - - -
2022-12-31 3.0 million - -

KZIA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 143.3 million
2023-06-30 156.8 million
2023-03-31 149.6 million
2022-12-31 99.2 million

KZIA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 4.0 million 2.8 million -
2023-06-30 - - - -
2023-03-31 - 2.1 million 1.4 million -
2022-12-31 - 6.4 million 2.9 million -

KZIA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 356 -
2023-06-30 - -
2023-03-31 186 -
2022-12-31 - -

KZIA

Price: $0.27

52 week price:
0.19
1.68

Earnings Per Share: -0.73 USD

P/E Ratio: -0.37

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 38900

Market Capitalization: 11.1 million

Links: